Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010
The Journal of Thoracic and Cardiovascular Surgery · 2023-03 · 165 (3) · 888-897
DOI: 10.1016/j.jtcvs.2022.08.009 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2023-03. Verfasst von Dong Chen und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Key Laboratory of Minimally Invasive …. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sun Yat-sen University, Ministry of Health of the People's Republic of China.
Abstract (Originalsprache)
OBJECTIVES: The prognosis of patients with locally advanced esophageal squamous cell carcinoma with different recurrence backgrounds is highly heterogeneous. This study aims to explore the effects of recurrence patterns on prognosis. METHODS: The phase III, multicenter, prospective NEOCRTEC5010 trial enrolled 451 patients with stage IIB-III esophageal squamous cell carcinoma randomly assigned to neoadjuvant chemoradiotherapy combined with surgery (NCRT group) or surgery alone (S group) and followed them long-term. We investigated the effects of recurrence patterns on survival in patients undergoing radical esophagectomy. RESULTS: In total, 353 patients were included in the study. The 5-year overall survival of patients with different recurrence patterns was significantly different: recurrence versus recurrence-free (17.8% vs 89.2%; P < .001), early recurrence versus late recurrence (4.6% vs 51.2%; P < .001), and distant metastasis versus locoregional recurrence (17.0% vs 20.0%; P = .666). Patients with early recurrence had significantly shorter survival after recurrence than those with late recurrence (hazard ratio, 1.541; 95% confidence interval, 1.047-2.268, P = .028). There was no significant difference in postrecurrence survival between patients with distant metastasis and locoregional recurrence (hazard ratio, 1.181; 95% confidence interval, 0.804-1.734; P = .396). Multivariate logistic analysis showed that pN1 stage, lymph node dissection
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejian…
- Department of Thoracic Surgery, Taizhou Hospital, Zhejiang University, Linhai, Zhejiang Province, China.
- Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, China.
- Department of Thoracic Surgery, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong Province, China.
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
- Department of Thoracic Surgery, Tianjin Medical University Cancer Hospital, Tianjin, China.
Förderung
- National Natural Science Foundation of China
- Sun Yat-sen University
- Ministry of Health of the People's Republic of China
- Science and Technology Planning Project of Guangdong Province
- Sun Yat-sen University Cancer Center
Zitieren
APA
Chen, D., Kong, M., Sun, J., Yang, H., Chen, Y., Fang, W., Yu, Z., Mao, W., Xiang, J., Han, Y., Chen, Z., Yang, H., Wang, J., Pang, Q., Zheng, X., Yang, H., Li, T., Zhang, X., Li, Q., …, & Zhu, C. (2023). Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010. The Journal of Thoracic and Cardiovascular Surgery, 165(3), 888-897. https://doi.org/10.1016/j.jtcvs.2022.08.009
Vancouver
Chen D, Kong M, Sun J, Yang H, Chen Y, Fang W, et al. Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010. The Journal of Thoracic and Cardiovascular Surgery. 2023;165(3):888-897. doi:10.1016/j.jtcvs.2022.08.009
BibTeX
@article{Chen2023,
author = {Chen, Dong and Kong, Min and Sun, Jiajing and Yang, Hong and Chen, Yuping and Fang, Wentao and Yu, Zhentao and Mao, Weimin and Xiang, Jiaqing and Han, Yongtao and Chen, Zhijian and Yang, Haihua and Wang, Jiaming and Pang, Qingsong and Zheng, Xiao and Yang, Huanjun and Li, Tao and Zhang, Xu and Li, Qun and Wang, Geng and Mao, Teng and Guo, Xufeng and Lin, Ting and Liu, Mengzhong and Witharana, Pasan and Fu, Jianhua and Chen, Baofu and Shen, Jianfei and Zhu, Chengchu},
title = {Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2023},
volume = {165},
number = {3},
pages = {888--897},
doi = {10.1016/j.jtcvs.2022.08.009}
}
EUVIMED